Application list for self inspection and registration of 7 clinical trial data

The official website of the State Drug Administration announced that it had decided to verify the clinical trial data of seven newly received drug registration applications that had completed the clinical trial declaration and production. According to the announcement, before the inspection organized by the State Drug Administration, if the drug registration applicant finds the authenticity of the drug clinical trial data through self inspection, he / she shall withdraw the registration application actively, and the State Drug Administration shall publish the list of drug registration applicants, and shall not investigate their responsibilities.The food and drug audit and inspection center of the State Drug Administration will publicize the on-site inspection plan on its website, and notify the drug registration applicant and its local provincial drug regulatory department. After 10 working days of publicity, the center will notify the on-site inspection date and no longer accept the withdrawal application of the drug registration applicant. For the applicant, the person in charge and manager of drug clinical trial, and the person in charge of contract research organization who found data fraud in the on-site verification of drug clinical trial data, SDA will deal with it seriously according to law. Application list for self inspection and registration of clinical trial data of 7 drugs
2026-07-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
6th Drug Safety Symposium 2026 to Focus on “Beyond Algorithms & Assumptions, What Actually Matters in Pharmacovigilance”
-
Roche Acquires Carmot for $3.1 Billion to Enter Obesity Drug Market
-
Two departments issued a document to guidethe strengthening of drug cases investigation and handling
-
National Health Care Commission: 50% of thecountry's public hospitals above the second level have carried out appointmentdiagnosis and treatment services
-
India starts testing a pharmaceuticalcompany's exports of cough syrup
-
Inmanar Announces Several BreakthroughSequencing Innovations
-
China's medical supplies supply securitycapabilities continue to enhance
-
244 medical device concept stocks roseindustry insiders said the process of domestic replacement is expected toaccelerate
-
Rare diseases pose a challenge to thepharmaceutical industry
-
Pfizer's $11.6 Billion Double-acting Migraine Drug Generates $318 Million in First-half Revenue
Recommend Reading
-
West Asia Tensions Squeeze Pharma Raw Materials
-
Iran Closes Strait of Hormuz to All Vessels: Global Chemical Trade Gets Choked
-
U.S. Onshoring Debate Exposes API Raw-Material Gap
-
Aldi Expands Its Ingredient Ban
-
IPEC Updates Excipient Qualification Guidance
-
Premium Global Chemical Sourcing Requests (1-5 Sep 2025)
-
Ammonium Sulfate Market Prices Slightly Increase (11.17-11.21) in China
-
Supply and Demand Drag Down Methylene Chloride in a Cliff-like Decline
-
This Week, China's Phenol Market Rises and Then Falls
-
On April 29, the market price of pure benzene in China was slightly increased